hyperparathyroidism: Hyperfunction of the parathyroid glands resulting in the overproduction of parathyroid hormone. It may be primary or secondary; primary hyperparathyroidism is caused by parathyroid adenoma, parathyroid hyperplasia, parathyroid carcinoma, and multiple endocrine neoplasia. It is associated with hypercalcemia and hypophosphatemia. Signs and symptoms include weakness, fatigue, nausea, vomiting, constipation, depression, bone pain, osteoporosis, cystic bone lesions, and kidney stones. Secondary hyperparathyroidism is caused by the chronic stimulation of the parathyroid glands in patients with chronic renal failure, rickets, and malabsorption syndromes.

Data source
FinnGen phenocode E4_HYPERPARA
Hospital Discharge registry ICD-10: E211/E210/E212/E213, ICD-8: 2520
Cause of Death registry ICD-10: E213/E211/E212/E210, ICD-8: 2520
Medicine purchases: ATC codes H05B
Level in the ICD-hierarchy 4
First defined in version DF2
DOID 13543
GWAS catalog 0008506
MESH D006961
SNOMED CT 66999008

Key figures

Sex All Female Male
Number of individuals 2811 2154 657
Unadjusted prevalence (%) 2.12 2.87 1.14
Mean age at first event (years) 64.32 64.71 63.04
Median number of events / individual 2 2 2

Clinical metrics

Sex All Female Male
Recurrence within 6 months (%) 51.33 53.16 45.36
Case fatality at 5-years (%) 10.42 9.01 15.07